These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4584149)

  • 1. Clinical biostatistics. XXIV. The role of randomization in sampling, testing, allocation, and credulous idolatry (conclusion).
    Feinstein AR
    Clin Pharmacol Ther; 1973; 14(6):1035-51. PubMed ID: 4584149
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical biostatistics. 23. The role of randomization in sampling, testing, allocation, and credulous idolatry. 2.
    Feinstein AR
    Clin Pharmacol Ther; 1973; 14(5):898-915. PubMed ID: 4729905
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical biostatistics. XXII. The role of randomization in sampling, testing, allocation, and credulous idolatry.
    Feinstein AR
    Clin Pharmacol Ther; 1973; 14(4):601-15. PubMed ID: 4723269
    [No Abstract]   [Full Text] [Related]  

  • 4. Methods of randomization in controlled clinical trials.
    Moeschberger ML; Williams JA; Brown CG
    Am J Emerg Med; 1985 Sep; 3(5):467-73. PubMed ID: 4041198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical biostatistics. 28. The biostatistical problems of pharmaceutical surveillance.
    Feinstein AR
    Clin Pharmacol Ther; 1974 Jul; 16(1):110-23. PubMed ID: 4843239
    [No Abstract]   [Full Text] [Related]  

  • 6. [Experimental designs for drug safety before the clinical trial].
    Fink H
    Methods Inf Med; 1973 Jul; 12(3):164-9. PubMed ID: 4580782
    [No Abstract]   [Full Text] [Related]  

  • 7. Statistical analyses of adverse event data from clinical trials. Special emphasis on serious events.
    O'Neill RT
    Drug Inf J; 1987; 21(1):9-20. PubMed ID: 10281640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The issue of side effects and the "blind ability" of clinical drug trials.
    Duberstein PR
    Am J Psychiatry; 1993 Nov; 150(11):1760; author reply 1760-1. PubMed ID: 8214203
    [No Abstract]   [Full Text] [Related]  

  • 9. The issue of side effects and the "blind ability" of clinical drug trials.
    Katz R; Deveaugh-Geiss J
    Am J Psychiatry; 1993 Nov; 150(11):1759-60; author reply 1760-1. PubMed ID: 8214202
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Is randomization always random?
    Barnett HL; Edelmann CM
    Pediatrics; 1974 Apr; 53(4):583-4. PubMed ID: 4595907
    [No Abstract]   [Full Text] [Related]  

  • 11. Rare adverse events in clinical trials: understanding the rule of three.
    Onakpoya IJ
    BMJ Evid Based Med; 2018 Feb; 23(1):6. PubMed ID: 29367316
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical biostatistics. XXXIV. The other side of 'statistical significance': alpha, beta, delta, and the calculation of sample size.
    Feinstein AR
    Clin Pharmacol Ther; 1975 Oct; 18(4):491-505. PubMed ID: 1164829
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical biostatistics XXXI. On the sensitivity, specificity, and discrimination of diagnostic tests.
    Feinstein AR
    Clin Pharmacol Ther; 1975 Jan; 17(1):104-16. PubMed ID: 1122664
    [No Abstract]   [Full Text] [Related]  

  • 14. Randomized clinical trials: design and analysis.
    Green SB
    Semin Oncol; 1981 Dec; 8(4):417-23. PubMed ID: 7323813
    [No Abstract]   [Full Text] [Related]  

  • 15. Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective.
    Lineberry N; Berlin JA; Mansi B; Glasser S; Berkwits M; Klem C; Bhattacharya A; Citrome L; Enck R; Fletcher J; Haller D; Chen TT; Laine C
    BMJ; 2016 Oct; 355():i5078. PubMed ID: 27697753
    [No Abstract]   [Full Text] [Related]  

  • 16. Integrating issues of efficacy, safety, and cost-effectiveness. Proceedings of the Fourth International Meeting on statistics Methods in Biopharmacy. Paris, France. September 24-25, 2001.
    Stat Med; 2003 Mar; 22(6):829-1039. PubMed ID: 12627402
    [No Abstract]   [Full Text] [Related]  

  • 17. Statistical concepts fundamental to investigations.
    Moses LE
    N Engl J Med; 1985 Apr; 312(14):890-7. PubMed ID: 3883178
    [No Abstract]   [Full Text] [Related]  

  • 18. Design and analysis of prostate cancer trials.
    Sylvester R
    Acta Urol Belg; 1994 Apr; 62(1):23-9. PubMed ID: 8197926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Fundamentals of intervention research].
    Tijssen JG; Lubsen J; Roelandt JR
    Ned Tijdschr Geneeskd; 1988 Oct; 132(44):2006-10. PubMed ID: 3185806
    [No Abstract]   [Full Text] [Related]  

  • 20. Experiences with evaluating the safety and efficacy of medical technologies.
    Moses LE; Brown BW
    Annu Rev Public Health; 1984; 5():267-92. PubMed ID: 6372811
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.